Overview

A Comparison of PF708 and Forteo in Osteoporosis Patients

Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of two teriparatide products, PF708 and Forteo, in patients with osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Pfenex, Inc
Treatments:
Teriparatide